Clinical Trial Update: A Dose-response Evaluation of the SQ Tree SLIT-tablet Using an Environmental Exposure Chamber [Phase 2]

View source ↗

Summary

A Phase 2 dose-response study evaluating the SQ Tree SLIT-tablet for allergic rhinoconjunctivitis using an environmental exposure chamber; the study is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• SQ Tree SLIT-tablet

Snippet

Sponsor: ALK-Abelló A/S | Conditions: Allergic Rhinoconjunctivitis | Phase 2 | Status: COMPLETED